CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center
Cosa include questo pacchetto
Procedure mediche
- Terapia con cellule CAR-T
- 3 pasti al giorno dal nutrizionista
- Servizi infermieristici 24 ore su 24
- TAC
- Esami del sangue
- Esame di follow-up
- Ecografia
- Ecocardiografia
- Esame di biochimica del sangue
- PET/TC
- Consultazione con un oncoematologo
- Emocromo completo con marcatori tumorali e proteinogramma
Durata
- 21 giorni in ospedale
- 7 giorni in albergo
Alloggio
Ospedalizzazione
Trasporto
Trasferimento aeroporto-clinica-aeroporto
Informazioni aggiuntive
CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center
For patients facing relapsed or resistant Non-Hodgkin lymphoma, finding the right treatment center can make a life-changing difference.
Sheba Medical Center, one of the world’s leading hospitals, offers advanced CAR-T cell therapy, providing new hope when standard treatments are no longer effective.
Sheba specializes in treating DLBCL, Follicular Lymphoma (FL), and Mantle Cell Lymphoma (MCL) with a highly personalized approach, combining cutting-edge science, speed, and clinical expertise.
A Faster Path to Treatment When Time Matters Most
At Sheba, the entire CAR-T process is performed on-site, without delays caused by external laboratories.
• T-cells are collected (apheresis)
• Genetically engineered at Sheba’s Advanced Biotherapy Center
• Reinfused to target and destroy lymphoma cells
This streamlined approach allows treatment to begin in approximately 10 days, significantly faster than many international centers.
CAR-T therapy acts as a “living drug”, continuing to work inside the body and offering the potential for long-term remission.
All patients are treated under the leadership of Prof. Arnon Nagler, a world-renowned expert in hemato-oncology.
Proven Results That Offer Real Hope
Even in complex and advanced cases, CAR-T therapy at Sheba has demonstrated high remission rates:
• Up to 90% in pediatric patients
• ~80% in young adults (up to 23 years old)
• ~70% in adults
These outcomes provide a meaningful second chance for patients who have exhausted other options.
Why Patients Choose Sheba
• Rapid access to treatment – no waiting weeks for cell production
• Extensive experience – one of the largest CAR-T programs in the region
• Dedicated CAR-T units – with 24/7 expert monitoring
• Multidisciplinary care – leading specialists working together on every case
• Full international support – from medical review to travel and coordination
Comprehensive, Personalized Care
Each patient undergoes a complete evaluation, including advanced imaging, genetic and molecular testing, and full medical assessment, ensuring the most effective, tailored treatment plan.
Services are available in English, Russian, and Arabic, making the experience smooth and supportive for international patients.
A Global Leader in Advanced Cancer Care
By combining speed, innovation, and world-class expertise, Sheba delivers one of the most advanced and accessible CAR-T programs for lymphoma patients worldwide, offering not just treatment, but a real opportunity for remission and renewed quality of life.
Assistenza Bookimed 24/7
- Coordinatore medico personale
- Organizzazione dei viaggi medici — prenotazione di biglietti aerei e camere d'albergo a prezzi speciali per i partner
- Tutela degli interessi dei pazienti durante il viaggio medico
Prezzo del programma
Cosa NON include questo pacchetto
Medico
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Com'è andata la tua esperienza?
Informazioni sulla clinica
La terapia con cellule CAR T presso lo Sheba Medical Center di Tel Aviv, Israele, può costare circa $63.100 per l'intero programma. L'ospedale è tra i primi 10 al mondo e offre questo trattamento avanzato sotto la guida del Prof. Arnon Nagler, uno specialista di spicco nel trapianto di midollo osseo.
Informazioni sul Trattamento
La terapia con cellule CAR T è un approccio innovativo per leucemia, linfoma e mieloma multiplo. Essa prevede la raccolta delle cellule T del paziente, la loro modifica genetica in laboratorio e l'infusione successiva dopo la chemioterapia. Il processo richiede 21 giorni di ricovero con possibile permanenza in terapia intensiva.
Cosa è Incluso
- Valutazione completa ($5.000-$10.000)
- Raccolta delle cellule tramite aferesi ($6.600)
- Preparazione in laboratorio delle cellule modificate ($20.000)
- Condizionamento chemioterapico ($5.000)
- Ricovero di 21 giorni ($31.500)
- Valutazione post-trattamento ($3.000-$5.000)
Preparazione e Recupero
I pazienti necessitano di biopsia del midollo osseo, scansioni PET/CT e analisi del sangue prima del trattamento. Dopo l'infusione, è previsto un monitoraggio giornaliero per la sindrome da rilascio di citochine. Il soggiorno totale raccomandato in Israele è di 4-6 settimane. Si noti che la terapia CAR-T per il mieloma è ancora sperimentale.
Lo Sheba Medical Center tratta 1,5 milioni di pazienti all'anno e fornisce assistenza multilingue. È richiesto un deposito di $50.000-$60.000 prima dell'arrivo. Contattare l'ospedale per discutere se questa terapia è adatta alla vostra condizione.
Pagamenti e Benefici
I nostri servizi sono gratuiti
Il pagamento viene effettuato direttamente presso la clinica oppure tramite bonifico sul loro conto bancario ufficiale.
Alcune cliniche possono richiedere un deposito come parte della loro politica.
Paghi comodamente a rate flessibili.
Ricevi premi per raccomandare Bookimed ai tuoi amici.